124 related articles for article (PubMed ID: 23941688)
1. Fine tuning of the pH-dependent drug release rate from polyHPMA-ellipticinium conjugates.
Sedláček O; Studenovský M; Větvička D; Ulbrich K; Hrubý M
Bioorg Med Chem; 2013 Sep; 21(18):5669-72. PubMed ID: 23941688
[TBL] [Abstract][Full Text] [Related]
2. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
[TBL] [Abstract][Full Text] [Related]
3. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
[TBL] [Abstract][Full Text] [Related]
4. Polymer conjugates of acridine-type anticancer drugs with pH-controlled activation.
Sedláček O; Hrubý M; Studenovský M; Větvička D; Svoboda J; Kaňková D; Kovář J; Ulbrich K
Bioorg Med Chem; 2012 Jul; 20(13):4056-63. PubMed ID: 22658535
[TBL] [Abstract][Full Text] [Related]
5. Ellipticine-aimed polymer-conjugated auger electron emitter: multistage organelle targeting approach.
Sedlacek O; Hruby M; Studenovsky M; Kucka J; Vetvicka D; Kovar L; Rihova B; Ulbrich K
Bioconjug Chem; 2011 Jun; 22(6):1194-201. PubMed ID: 21513348
[TBL] [Abstract][Full Text] [Related]
6. N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation.
Chytil P; Etrych T; Kříž J; Subr V; Ulbrich K
Eur J Pharm Sci; 2010 Nov; 41(3-4):473-82. PubMed ID: 20696244
[TBL] [Abstract][Full Text] [Related]
7. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Etrych T; Sírová M; Starovoytova L; Ríhová B; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1015-26. PubMed ID: 20518512
[TBL] [Abstract][Full Text] [Related]
8. Multi-responsive polymer micelles as ellipticine delivery carriers for cancer therapy.
Studenovský M; Sedláček O; Hrubý M; Pánek J; Ulbrich K
Anticancer Res; 2015 Feb; 35(2):753-7. PubMed ID: 25667454
[TBL] [Abstract][Full Text] [Related]
9. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
[TBL] [Abstract][Full Text] [Related]
10. Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release II: impact of release rate on biodistribution.
Chytil P; Hoffmann S; Schindler L; Kostka L; Ulbrich K; Caysa H; Mueller T; Mäder K; Etrych T
J Control Release; 2013 Dec; 172(2):504-12. PubMed ID: 23697767
[TBL] [Abstract][Full Text] [Related]
11. Multistage-targeted pH-responsive polymer conjugate of Auger electron emitter: optimized design and in vivo activity.
Sedlacek O; Kucka J; Mattova J; Parizek M; Studenovsky M; Zadinova M; Pouckova P; Hruby M
Eur J Pharm Sci; 2014 Oct; 63():216-25. PubMed ID: 25110352
[TBL] [Abstract][Full Text] [Related]
12. Hydrolytically degradable polymer micelles for drug delivery: a SAXS/SANS kinetic study.
Filippov SK; Franklin JM; Konarev PV; Chytil P; Etrych T; Bogomolova A; Dyakonova M; Papadakis CM; Radulescu A; Ulbrich K; Stepanek P; Svergun DI
Biomacromolecules; 2013 Nov; 14(11):4061-70. PubMed ID: 24083567
[TBL] [Abstract][Full Text] [Related]
13. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Zhou Z; Li L; Yang Y; Xu X; Huang Y
Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of a new polymer drug delivery conjugate.
Christie RJ; Findley DJ; Grainger DW
Biomed Sci Instrum; 2004; 40():136-41. PubMed ID: 15133948
[TBL] [Abstract][Full Text] [Related]
15. Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent.
Liu J; Zeng F; Allen C
J Control Release; 2005 Mar; 103(2):481-97. PubMed ID: 15763628
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistry.
Christie RJ; Anderson DJ; Grainger DW
Bioconjug Chem; 2010 Oct; 21(10):1779-87. PubMed ID: 20695431
[TBL] [Abstract][Full Text] [Related]
17. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP
Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235
[TBL] [Abstract][Full Text] [Related]
18. Preparation of pH-responsive polymer core-shell nanospheres for delivery of hydrophobic antineoplastic drug ellipticine.
Wang H; Yang L; Rempel GL
Macromol Biosci; 2014 Feb; 14(2):166-72. PubMed ID: 24106137
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
Franssen EJ; Koiter J; Kuipers CA; Bruins AP; Moolenaar F; de Zeeuw D; Kruizinga WH; Kellogg RM; Meijer DK
J Med Chem; 1992 Apr; 35(7):1246-59. PubMed ID: 1560438
[TBL] [Abstract][Full Text] [Related]
20. N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production.
Koziolová E; Kostka L; Kotrchová L; Šubr V; Konefal R; Nottelet B; Etrych T
Biomacromolecules; 2018 Oct; 19(10):4003-4013. PubMed ID: 30180562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
